Goldline Pharmaceutical IPO is scheduled to list on 19 May 2026 on NSE, BSE.
Listed
SME IPO
GOLDLINE
Goldline Pharmaceutical IPO Listing Price ₹59.75, Listing Gain +38.95%
Goldline Pharmaceutical IPO listed on 19 May 2026 at ₹59.75 against an issue price of ₹43, a listing gain of +38.95%.
- Issue price
- ₹43
- Actual listing price
- ₹59.75
- Listing Date
- 19 May 2026
- Exchange
- NSE, BSE
Live share price
Goldline Pharmaceutical share price
-
vs issue price
Open-
Day high-
Day low-
Exchange-
Loading live price…
The live price isn't available right now. Check back shortly.
Source: Yahoo Finance. Prices may be delayed by a few minutes.
GMP vs actual
Goldline Pharmaceutical listing price vs GMP estimate
| Issue price | ₹43 |
|---|---|
| Latest GMP | ₹16.75 (+38.95%) |
| Expected listing price (issue price + GMP) | ₹59.75 |
| Actual listing price | ₹59.75 |
| Listing gain | +38.95% |
| Difference from GMP estimate | +₹0 (+0.00%) |
Profit per application
₹1,00,500
At the listing price, for 6,000 shares
GMP is an unofficial grey market indicator, not a guarantee of the listing price.
GMP trend
Goldline Pharmaceutical GMP trend before listing
| Date | GMP | Change |
|---|---|---|
| 14 May 2026 | ₹18.00 | - |
| 13 May 2026 | ₹18.00 | +1 |
| 12 May 2026 | ₹17.00 | - |
Listing day
Listing day timings
| Listing Date | 19 May 2026 |
|---|---|
| Special pre-open session | 9:00 AM - 9:45 AM |
| Normal trading starts | 10:00 AM |
| Exchange | NSE, BSE |
FAQ
Goldline Pharmaceutical IPO: frequently asked questions
Goldline Pharmaceutical IPO listed at ₹59.75 against an issue price of ₹43, a listing gain of +38.95%.
On listing day, a special pre-open session runs from 9:00 AM to 9:45 AM to set the listing price. Goldline Pharmaceutical shares then start normal trading at 10:00 AM.
At the listing price, one minimum application of 6,000 shares in Goldline Pharmaceutical IPO made about ₹1,00,500.